Meeting Highlights
Miami, March 27, 2009
Maui, January 14-17, 2009
San Francisco, October 24-29, 2008
Paris, June 11-14, 2008
Chicago, April 10, 2008
San Francisco, March 5-9, 2008
Affiliations
Consumer News
Monday, February 11, 2008 Chronic Pain Harms Brain's Wiring
Patients with chronic low back pain experience a constant firing of neurons in the front region of the cortex, which could cause permanent damage...
Thursday, February 07, 2008 Supplement Shows Promise for Mild Knee Arthritis
A dietary supplement derived from chickens may relieve the pain in patients with mild knee arthritis...
Tuesday, February 05, 2008 MGH Center is a Pioneer in Knee Repair
Physicians at the Massachusetts General Hospital sports medicine center are experimenting with new techniques for joint reconstruction in athletes...
Thursday, January 31, 2008 Financial Ties Are Cited as Issue in Spine Study
Many of the spine surgeons who hailed the Prodisc® as a medical breakthrough had a financial interest in the new product…
Tuesday, January 29, 2008 Newer Rheumatoid Arthritis Drugs Lower Production of B Cells
New findings suggest that drugs such as Enbrel®, Humira®, and Remicade® reduce activity of abnormal B-cells, benefiting the patient's immune system...
Thursday, January 24, 2008 NSAIDs No Better for Low Back Pain
Acetaminophen has been found to provide comparable relief to nonsteroidal anti-inflammatory drugs (NSAIDs) for low back pain...
Tuesday, January 22, 2008 New Jersey Investigating Amgen's Marketing of a Psoriasis Drug
New Jersey's attorney general is investigating biotechnology company Amgen Inc over possible patient confidentiality law violations in their efforts to sell Enbrel®â€¦
Thursday, January 17, 2008 Too Much of a Good Thing?
Growing use of CT scans is causing concern about radiation exposure...
Monday, January 14, 2008 Drug Approved. Is Disease Real?
As Pfizer markets Lyrica® (pregabalin), the first approved medicine to treat fibromyalgia, doctors debate the legitimacy of the pain syndrome...
Friday, January 11, 2008 Judge Calls Celebrex® Evidence Unreliable
A New York state court has ruled that there is no reliable scientific evidence to prove that the pain medication Celebrex® causes heart attack and stroke…